Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond--a commentary based on clinical experience.

about

Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System-A Review of 10 Years of Clinical Experience Why perimenopausal women should consider to use a levonorgestrel intrauterine system.

P2860

Q26740182-2934AFA4-613E-469C-B191-C7518E0C3043 Q49068672-FA420809-6A47-4A16-9467-7DA3D3BE92F9

P2860

Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond--a commentary based on clinical experience.

Item

http://www.wikidata.org/entity/Q46664316

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Potential health benefits of c ...... based on clinical experience.

@en

Potential health benefits of c ...... based on clinical experience.

@nl

type

Item

label

Potential health benefits of c ...... based on clinical experience.

@en

Potential health benefits of c ...... based on clinical experience.

@nl

prefLabel

Potential health benefits of c ...... based on clinical experience.

@en

Potential health benefits of c ...... based on clinical experience.

@nl

P1476

Potential health benefits of c ...... based on clinical experience.

@en

P2093

Dirk Wildemeersch

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Breast cancer and hormone-replacement therapy in the Million Women Study.

Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life.

Estrogen and cognitive functioning in women.

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.

Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis

P304

569-573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09513590.2013.774364

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23465041

http://www.w3.org/2001/XMLSchema#string

Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond--a commentary based on clinical experience.

about

P2860

P2860

Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond--a commentary based on clinical experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698